An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi

Annals of Tropical Medicine and Parasitology

Volumn 92, Issue 2, 1998, Pages 141-150

  Verhoeff, F H ^a,b   Brabin, B J ^a   Chimsuku, L ^a,c   Kazembe, P ^d   Russell, W B ^a   Broadhead, R L ^c  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b LEIDEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF MALAWI   (Malawi)

^d Lilongwe Central Hospital   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; FANSIDAR; HEMOGLOBIN;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DRUG SAFETY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALAWI; MATERNAL DISEASE; MOTHER; PARASITE PREVALENCE; PLASMODIUM FALCIPARUM; PREGNANCY; REGRESSION ANALYSIS; RISK ASSESSMENT; SEROPREVALENCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA; AFRICA SOUTH OF THE SAHARA; ANEMIA; BIOLOGY; BIRTH WEIGHT; BODY WEIGHT; CORRELATION STUDIES; DEMOGRAPHIC FACTORS; DEVELOPING COUNTRIES; DISEASES; DRUGS; EASTERN AFRICA; ENGLISH SPEAKING AFRICA; FERTILITY; FERTILITY MEASUREMENTS; HIV INFECTIONS; LOW BIRTH WEIGHT; MALARIA; MALAWI; PARASITIC DISEASES; PARITY; PHYSIOLOGY; POPULATION; POPULATION CHARACTERISTICS; POPULATION DYNAMICS; PREGNANCY; PREGNANT WOMEN; REPRODUCTION; RESEARCH METHODOLOGY; RESEARCH REPORT; RISK FACTORS; STATISTICAL STUDIES; STUDIES; TREATMENT; VIRAL DISEASES;

ADOLESCENT; ADULT; ANTIMALARIALS; BIRTH WEIGHT; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MALARIA, FALCIPARUM; MALAWI; PARASITEMIA; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PYRIMETHAMINE; SULFADOXINE;

HUMAN IMMUNODEFICIENCY VIRUS; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0031909871     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1080/00034989859979     Document Type: Article

References (24)

1. ANON, (1997). Kenya National Malaria Control Guidelines. Nairobi: Ministry of Health.
2. BLOLAND, P. B., LACKRITZ, E. M., KAZEMBE, P. N., WERE, J. B., STEKETEE, R. & CAMPBELL, C. C. (1993). Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. Journal of Infectious Diseases, 167, 932-937.
3. BRABIN, B. J. (1983). An analysis of malaria in pregnancy in Africa. Bulletin of the World Health Organization, 61, 1005-1016.
4. BRABIN, B. J. (1991). An assessment of low birth weight risk in primigravidae as an indicator of malaria control in pregnancy. International Journal of Epidemiology, 20, 276-283.
5. BRABIN, B. J. & PIPER, C. (1997). Anaemia and malaria attributable to low birthweight in two populations in Papua New Guinea. Annals of Human Biology, 24, 547-555.
6. BRABIN, B. J., VERHOEFF, F. H., KAZEMBE, P., CHIMSUKU, L. & BROADHEAD, R. (1997a). Antimalarial drug policy in Malawi. Annals of Tropical Medicine and Parasitology, 91 (Suppl. 1), S113-S115.
7. BRABIN, L., VERHOEFF, F. H., KAZEMBE, P., BRABIN, B. J., CHIMSUKU, L. & BROADHEAD, R. (1997b). Improving antenatal care for pregnant adolescents in southern Malawi. Acta Obstetrica and Gynecologica Scandinavica, in press.
8. COOK, G. C. (1992). Use of antiprotozoan and antihelmintic drugs during pregnancy: side effects and contra-indications. Journal of Infection, 25, 1-9.
9. COT, M., LE HESRAN, J. Y., MIAILHES, P., ESVELD, M., ETYA'ALE, D. & BREART, G. (1995). Increase of birthweight following chloroquine prophylaxis during first pregnancy: results of a randomised trial in Cameroon. American Journal of Tropical Medicine and Hygiene, 53, 581-585.
10. GARNER, P. & BRABIN, B. J. (1994). A review of randomized controlled trials of routine antimalarial drug prophylaxis during pregnancy in endemic malarious areas. Bulletin of the World Health Organization, 72, 89-99.
11. GREENWOOD, B. M., GREENWOOD, A. M., SNOW, R. W., BYASS, P., BENNETT, S. & HATIB N'JIE, A. B. (1989). The effects of malaria chemoprophylaxis given by traditional birth attendants on the course and outcome of pregnancy. Transactions of the Royal Society of Tropical Medicine and Hygiene, 83, 589-594.
12. HELITZER-ALLEN, D. L., MCFARLAND, D. A., WIRIMA, J. J. & MACHESO, A. P. (1993). Malaria chemoprophylaxis compliance in pregnant women: a cost effectiveness analysis of alternative interventions. Social Science and Medicine, 36, 403-407.
13. HEYMANN, D. L., STEKETEE, R. W., WIRIMA, J. J., MCFARLAND, D. A., KHOROMANA, C. O. & CAMPBELL, C. C. (1990). Antenatal chloroquine prophylaxis in Malawi: chloroquine resistance, compliance, protective efficacy and cost. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 496-498.
14. HOWORTH, P. (1996). Haematological and parasitological parameters in a cohort of pregnant women, M.Trop.Med. thesis, University of Liverpool, U.K.
15. IMAM, M. (1996). A review of two years experience of malaria prophylaxis in pregnancy in Mangochi district, Malawi. M.Trop.Med. thesis, University of Liverpool, U.K.
16. MCDERMOTT, J. M., HEYMANN, D. L., WIRIMA, J. J., MACHESO, A. P., WAHL, R. D., STEKETEE, R. W. & CAMPBELL, C. C. (1988). Efficacy of chemoprophylaxis in preventing Plasmodium falciparum parasitaemia and placental infection in pregnant women in Malawi. Transactions of the Royal Society of Tropical Medicine and Hygiene, 82, 520-523
17. MCGREGOR, I. A. (1984). Epidemiology, malaria and pregnancy. American Journal of Tropical Medicine and Hygiene, 33, 517-525.
18. MENENDEZ, C., TODD, J., ALONSO, P. L., LULAT, S., FRANCIS, N. & GREENWOOD, B. M. (1994). Malaria chemoprophylaxis, infection of the placenta and birth weight in Gambian primigravidae. Journal of Tropical Medicine and Hygiene, 97, 244-248.
19. MORLEY, D., WOODLAND, M. & CUTHBERTSON, W. F. J. (1964). Controlled trial of pyrimethamine in pregnant women in an African village. British Medical Journal, i, 667-668.
20. MUTABINGWA, T. K., MALLE, L. N., DE GEUS, A. & OOSTING, J. (1993). Malaria chemosuppression during pregnancy. 1. Effect of chemosuppressive drugs on maternal parasitaemia. Tropical and Geographical Medicine, 45, 6-14.
21. NYIRJESY, P., KAVASYA, T., AXELROD, P. & FISCHER, P. R. (1993). Malaria during pregnancy: neonatal morbidity and mortality and the efficacy of chloroquine prophylaxis. Clinical Infectious Diseases, 16, 127-132.
22. SCHULTZ, L. J., STEKETEE, R. W., MACHESO, A., KAZEMBE, P., CHITSULO, L. & WIRIMA, J. J. (1994). The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. American Journal of Tropical Medicine and Hygiene, 51, 515-521.
23. STEKETEE, R. W., BRANDLING-BENNET, A. D., KASAJE, D. C. O., SCHWARTZ, I. K. & CHURCHILL, F. C. (1987). In vivo response of Plasmodium falciparum to chloroquine in pregnant and non-pregnant women in Siaya district, Kenya. Bulletin of the World Health Organization, 65, 885-890.
24. WORLD HEALTH ORGANIZATION (1986). Expert Committee on Malaria, 18th Report. Technical Report Series No. 735 Geneva: WHO.